Konstantina Ismini Tsezou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Konstantina Ismini Tsezou has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Aswin Verhoeven
Leiden University Medical Center
1 shared publication - Emmanuel Mikros
Division of Pharmaceutical Chemistry Department of Pharmacy National and Kapodistrian University of Athens Athens Greece
1 shared publication - Martin Giera
Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands
1 shared publication - Mohan Ghorasaini
Center for Proteomics and Metabolomics, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands
1 shared publication - Panayiotis G. Vlachoyiannopoulos
Department of Pathophysiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece
1 shared publication - Yassene Mohammed
Lady Davis Institute for Medical Research, Jewish General Hospital
1 shared publication
Latest Publications
- Open Access
- 27 October 2022
- Published by MDPI AG in Metabolites
- Vol. 12 (11) , 1030
Congruence and Complementarity of Differential Mobility Spectrometry and NMR Spectroscopy for Plasma Lipidomics
The lipid composition of lipoprotein particles is determinative of their respective formation and function. In turn, the combination and correlation of nuclear magnetic resonance (NMR)-based lipoprotein measurements with mass spectrometry (MS)-based lipidomics is an appealing technological combination for a better understanding of lipid metabolism in health and disease. Here, we developed a combined workflow for subsequent NMR- and MS-based analysis on single sample aliquots of human plasma. We evaluated the quantitative agreement of the two platforms for lipid quantification and benchmarked our combined workflow. We investigated the congruence and complementarity between the platforms in order to facilitate a better understanding of patho-physiological lipoprotein and lipid alterations. We evaluated the correlation and agreement between the platforms. Next, we compared lipid class concentrations between healthy controls and rheumatoid arthritis patient samples to investigate the consensus among the platforms on differentiating the two groups. Finally, we performed correlation analysis between all measured lipoprotein particles and lipid species. We found excellent agreement and correlation (r > 0.8) between the platforms and their respective diagnostic performance. Additionally, we generated correlation maps detailing lipoprotein/lipid interactions and describe disease-relevant correlations.
- 27 October 2022
- Published by MDPI AG in Metabolites
- Vol. 12 (11) , 1030
Open AccessCongruence and Complementarity of Differential Mobility Spectrometry and NMR Spectroscopy for Plasma Lipidomics
The lipid composition of lipoprotein particles is determinative of their respective formation and function. In turn, the combination and correlation of nuclear magnetic resonance (NMR)-based lipoprotein measurements with mass spectrometry (MS)-based lipidomics is an appealing technological combination for a better understanding of lipid metabolism in health and disease. Here, we developed a combined workflow for subsequent NMR- and MS-based analysis on single sample aliquots of human plasma. We evaluated the quantitative agreement of the two platforms for lipid quantification and benchmarked our combined workflow. We investigated the congruence and complementarity between the platforms in order to facilitate a better understanding of patho-physiological lipoprotein and lipid alterations. We evaluated the correlation and agreement between the platforms. Next, we compared lipid class concentrations between healthy controls and rheumatoid arthritis patient samples to investigate the consensus among the platforms on differentiating the two groups. Finally, we performed correlation analysis between all measured lipoprotein particles and lipid species. We found excellent agreement and correlation (r > 0.8) between the platforms and their respective diagnostic performance. Additionally, we generated correlation maps detailing lipoprotein/lipid interactions and describe disease-relevant correlations.